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Abstract
Introduction:  Endoscopic  submucosal  dissection  (ESD)  is  a  minimally  invasive  organ-sparing
endoscopic  technique  which  allows  en  bloc  resection  of  premalignant  and  early  malignant
lesions of  the  gastrointestinal  tract  regardless  of  size.  In  spite  of  the  promising  results,  mainly
from Japanese  series,  ESD  is  still  not  being  widely  used  in  western  countries.  This  study  aims  to
report the  feasibility,  safety  and  effectiveness  of  ESD  technique  for  treating  premalignant  and
early malignant  gastrointestinal  (GI)  lesions  (esophagus,  gastric  and  rectum)  in  a  Portuguese
center.
Patient and  Methods: From  December  2011  to  November  2014,  34  GI  lesions  were  treated  by
ESD. The  location,  en  bloc  and  pathological  complete  resection  (R0)  rates,  procedure  time,
complications  and  local  recurrence  were  retrospectively  evaluated.
Results:  From  34  resected  lesions,  18  were  gastric  (GL),  15  were  rectal  (RL)  and  one  esophageal
(EL). En  bloc  resection  for  each  location  was  17/18  (94%),  11/15  (73%)  and  1/1  respectively.
R0 was  achieved  in  16/18  (89%)  GL,  9/15  (60%)  RL  and  1/1  EL.  Mean  resection  time  was  67  min
for GL,  142  min  for  RL  and  40  min  for  EL.  Complications  included  immediate  (6%)  and  delayed
(3%) minor  bleeding  but  no  perforation.  One  local  residual  lesion  from  a  RL  was  reported  in
the follow-up,  effectively  treated  with  an  endoscopic  technique.  Disease-speciﬁc  survival  was
100% over  a  mean  follow-up  period  of  14  months.
Conclusion:  ESD  has  shown  to  be  a  safe  and  feasible  resection  method,  achieving  high  R0,
low recurrence  and  complication  rates.  Our  results  are  similar  to  those  reported  in  other
international  series.
©  2015  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.
cle  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/This is  an  open  access  arti
licenses/by-nc-nd/4.0/).∗ Corresponding author.
E-mail address: pedrobarreiro@msn.com (P. Barreiro).
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Dissecc¸ão  Endoscópica  da  Submucosa  para  Lesões  Gastrointestinais  Superﬁciais:
Experiência  Inicial  de  um  Único  Centro  Português
Resumo
Introduc¸ão:  A  dissecc¸ão  endoscópica  da  submucosa  (DES)  é  uma  técnica  minimamente  invasiva
que permite  a  ressecc¸ão  em  bloco  de  lesões  gastrointestinais  pré-malignas  e  malignas  precoces
independentemente  do  seu  tamanho.  Apesar  dos  resultados  promissores,  principalmente  em
séries Japonesas,  a  DES  ainda  não  é  executada  de  forma  generalizada  no  mundo  Ocidental.
O objetivo  do  estudo  é  reportar  a  exequibilidade,  seguranc¸a e  eﬁcácia  da  técnica  de  DES  no
tratamento  de  lesões  pré-malignas  e  malignas  precoces  do  tubo  digestivo  (esófago,  estômago
e reto)  num  centro  Português.
Doentes  e  Métodos: Entre  dezembro  de  2011  e  novembro  de  2014,  34  lesões  gastrointestinais
foram excisadas  por  DES.  A  sua  localizac¸ão,  taxas  de  ressecc¸ão  em  bloco  e  ressecc¸ão  histológica
completa  (R0),  tempo  do  procedimento  e  recidiva  local  foram  avaliados.
Resultados:  De  34  lesões  ressecadas,  18  foram  gástricas  (LG),  15  foram  rectais  (LR)  e  uma
esofágica (LE).  A  ressecc¸ão  em  bloco  em  cada  localizac¸ão  foi  de  17/18  (94%),  11/15  (73%)  e
1/1 respetivamente.  A  ressecc¸ão  foi  considerada  R0  em  16/18  (89%)  LG,  9/15  (60%)  LR  e  1/1
LE. Os  tempos  médios  de  ressecc¸ão  foram  de  67  min  para  LG,  142  min  para  LR  e  40  min  para
LE. As  complicac¸ões  registadas  incluíram  hemorragia  imediata  (6%)  e  tardia  (3%),  sem  casos
de perfurac¸ão.  Durante  o  período  de  seguimento  é  reportada  uma  lesão  residual  de  uma  LR,
tratada eﬁcazmente  por  técnica  endoscópica.  Veriﬁcou-se  uma  sobrevida  especíﬁca  da  doenc¸a
de 100%  durante  um  período  médio  de  seguimento  de  14  meses.
Conclusão:  A  técnica  de  DES  revelou  ser  segura  e  exequível,  atingindo  uma  elevada  taxa  de
R0 e  baixas  taxas  de  recidiva  e  complicac¸ões.  Os  resultados  apresentados  são  semelhantes  aos
reportados  em  outras  séries  internacionais.
© 2015  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.
Este é  um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/
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were  adapted  from  those  proposed  by  the  Colorectal  ESD
Standardization  Implementation  Working  Group  and  are
shown  in  Table  1.13 Subepithelial  lesions  with  more  than
10  mm  were  also  included.
Table  1  Indications  for  CR-ESD.
1.  LST-NG  ≥2  cm.
2.  LST-G  (mixed  type)  ≥4  cm.
3. Mucosal  lesion  with  ﬁbrosis  resulting  in  positive
non-lifting-sign.
4. Suspected  minimal  invasive  lesion  (e.g.  Kudo  VI pit
pattern)  endoscopically  resectable.licenses/by-nc-nd/4.0/).
1. Introduction
Endoscopic  submucosal  dissection  (ESD)  was  ﬁrst  described
by  Hirao  et  al.  in  the  80s  and  is  characterized  by  three  basic
steps:  ﬂuid  injection  into  the  submucosa  to  separate  the
lesion  from  the  muscle  layer,  circumferential  cutting  of  the
surrounding  mucosa  and  dissection  of  the  connective  tissue
of  the  submucosa  beneath  the  lesion.1,2
This  minimally  invasive  organ-sparing  endoscopic  tech-
nique  allows  en  bloc  resection  of  premalignant  and  early
malignant  lesions  of  the  gastrointestinal  tract,  regardless  of
size,  avoiding  surgical  morbidity.  Comparing  to  endoscopic
mucosal  resection  (EMR),  ESD  contributes  to  a  better  his-
tological  analysis,  lower  local  recurrence  rate  and  more
curative  resections.3,4
In  spite  of  the  promising  results  from  Japanese  and  recent
western  series,  ESD  is  still  not  being  widely  used  in  western
countries.5--8
The  aim  of  this  study  is  to  report  the  feasibility,  safety
and  effectiveness  of  ESD  technique  for  treating  prema-
lignant  and  early  malignant  gastrointestinal  (GI)  lesions
(esophagus,  gastric  and  rectum)  in  a  European  center.
2. Patients and Methods2.1.  Pre-procedure  evaluation
Before  the  procedure  a  careful  endoscopic  staging
was  performed  to  all  lesions.  Morphological  endoscopiclassiﬁcation  was  made  according  to  Paris  classiﬁcation,9
nd  every  sign  suggestive  of  invasive  lesion  (e.g.  Kudo  VN)
as  looked  for.10 When  there  were  doubts  about  possible
eep  invasion,  complementary  endoscopic  ultrasonography
EUS)  staging  was  made.
All  lesions  had  previous  endoscopic  biopsies  conﬁrming
heir  neoplastic  nature  (pre-malignant  or  malignant  lesions).
We  proposed  ESD  for  gastric  and  esophageal  pre-
alignant  or  early  malignant  lesions,  with  more  than  10  mm,
ith  possibility  of  endoscopic  curability  based  on  Japanese
riteria  (Japanese  Gastric  Cancer  Association  and  Japan
sophageal  Society  Guidelines).11,12
ESD  indications  for  rectal  neoplastic  lesions  treatmentCR-ESD: colorectal endoscopic submucosal dissection; DBE:
double balloon enteroscopy; LST-NG: lateral spreading tumor
non-granular type; LST-G: lateral spreading tumor granular type.
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The  procedures  were  performed  after  a  multidisciplinary
roup  decision  and  with  the  consent  of  the  patients,  after
xplaining  the  risks  and  beneﬁts  of  the  method  and  other
herapeutic  options.
.2.  Technical  aspects  of  ESD  procedures
astric  and  esophageal  ESD  were  performed  under  general
nesthesia  with  orotracheal  intubation  for  airway  protection
hile  in  the  rectum  just  superﬁcial  sedation  with  midazo-
am  was  done.  The  patients  were  monitored  with  continuous
lectrocardiographic  registration,  pulse  oximetry  and  non-
nvasive  blood  pressure  measurement.
All  procedures  were  done  with  conventional  gastroscopes
r  colonoscopes  (Olympus  GIF-Q165)  with  soft  straight  dis-
al  attachments  (Olympus)  using  Dual-Knife  and/or  IT-Knives
Olympus).  For  the  different  steps  of  the  resection  proce-
ure,  the  ERBE  ICC  200  electrosurgical  generator  was  used:
ndocut  mode  for  mucosal  incision;  forced  coagulation  for
ubmucosal  dissection;  soft  coagulation  for  hemostasis.  Car-
on  dioxide  was  used  for  insufﬂation.
The  following  main  steps  were  performed:  (1)  careful
nspection  of  the  lesion  to  determine  the  lateral  margins
ith  white  light  endoscopy  and  usually  chromoendoscopy  for
astric  and  esophageal  lesions;  (2)  marking  the  borders  of
he  lesion  using  soft  coagulation  current  with  the  Dual  Knife
not  performed  in  rectal  lesions);  (3)  submucosal  solution
njection  with  Voluven®,  indigo  carmine  and  epinephrine
1:250,000)  to  create  a  submucosal  cushion  underneath  the
esion;  (4)  mucosal  incision  was  then  made  using  Dual  Knife
nd/or  It  Knife;  for  gastric  lesions,  complete  circumfer-
ntial  incision  was  always  made  before  starting  submucosal
issection  (not  always  performed  in  the  others  locations);
5)  complete  submucosal  dissection  under  the  base  of  the
esion  using  Dual  Knife  and/or  It  Knife;  during  this  phase
epeated  submucosal  injection  whenever  needed  and  coag-
lation  of  visible  vessels  were  performed;  (6)  at  the  end,
areful  inspection  of  the  ulcer  looking  for  complications;
oagulation  of  visible  vessels  was  routinely  performed.
.3.  Histopathological  assessment
esection  specimens  were  minimally  stretched  and  ﬁxed
nto  cork  with  needles.  In  cases  of  piecemeal  resections,
f  possible,  the  specimen  was  reconstructed  by  appropri-
te  ﬁxation  onto  cork.  Specimen  size  was  measured  and
hen  it  was  sent  for  histopathological  assessment  ﬁxed  in
ormalin.  Histopathological  work-up  provided  information
bout  lesion  diameter,  invasion  depth,  grading,  presence  or
bsence  of  lymphovascular  invasion  and  lateral  and  vertical
argins.
.4.  Post-procedure  protocol  and  follow-up
ll  patients  were  admitted  for  surveillance  and  those  who
nderwent  upper  GI  ESD  proton  pump  inhibitors  were  admin-
stered  (40  mg  two  times  per  day)  for  4--8  weeks.  Oral  liquid
iet  was  started  in  the  following  day  with  discharge  at  24-
2H  after  the  procedure,  in  the  absence  of  complications.
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All  patients  had  a  follow  up  endoscopy  with  scar  biop-
ies  at  3,  6  and  12  months  after  the  procedure.  Then,  and  if
o  residual  lesion  was  identiﬁed,  annual  endoscopic  surveil-
ance  was  indicated  for  upper  GI  resections  and  every  2--3
ears  for  rectal  lesions.
.5.  Endoscopic  outcomes  and  deﬁnitions
esection  was  deﬁned  as  en  bloc  when  the  lesion  was
esected  in  one  piece,  and  piecemeal  if  in  two  or  more
ieces.  A  complete  resection  (R0)  was  considered  when  the
esection  was  en  bloc  and  both  lateral  and  vertical  mar-
ins  were  free  of  lesion;  incomplete  resection  (R1)  when
he  lesion  invaded  at  least  one  of  the  margins  (vertical  or
ateral).  When  an  adequate  evaluation  of  the  margins  was
ot  possible,  by  fragmentation  or  coagulation  effects,  and
omplete  resection  was  not  ensured  it  was  deﬁned  as  Rx.
In  endoscopic  surveillance,  a  residual  disease  was  deﬁned
s  the  presence  of  lesion  at  the  same  place  where  ESD  was
erformed  following  a  non-R0  resection,  found  in  the  ﬁrst  or
econd  endoscopic  controls;  after  this  period  or  if  resection
as  R0  it  was  considered  local  recurrence.  A  lesion  found  in
nother  place  during  follow-up  was  deﬁned  as  metachronous
esion.
Bleeding  and  perforation  are  the  most  common
omplications.  Immediate  bleeding,  observed  during  the
rocedure,  was  considered  major  when  it  led  to  a
ecrease  in  hemoglobin  level  >2  g/dL,  hemodynamic  insta-
ility  and/or  surgery  was  necessary.  As  minimal  immediate
leeding  occurs  in  almost  all  procedures  we  have  just  con-
idered  minor  immediate  bleeding  as  a  complication  when
t  changed  the  procedure  plan  (e.g.  use  of  hemoclips)  or
ook  ≥5  min  to  be  controlled  by  endoscopy  (without  meeting
riteria  for  major  bleeding).  Delayed  bleeding,  was  deﬁned
hen  there  was  clinical  evidence  of  bleeding  (melena,
ematemesis  or  haematochezia)  that  occurred  until  30  days
fter  the  ESD.  Another  potentially  dangerous  complication
f  ESD  is  perforation.  It  was  considered  major  or  minor  if
t  was  radiologically  evident  with  or  without  a  visible  wall
efect,  respectively.
. Results
rom  December  2011  to  November  2014,  thirty-three
atients,  corresponding  to  thirty-four  lesions,  underwent
SD  at  our  institution  for  treatment  of  gastrointestinal
esions:  18  gastric  (n  =  18,  53%),  15  in  the  rectum  (n  =  15,
4%)  and  one  in  the  esophagus  (n  =  1,  3%).  In ﬁve  lesions
US  was  performed  previously  to  lesion  resection.  In  all
ases  no  submucosal  or  local  nodes  invasion  was  suspected.
ne  endoscopist  (P.  B.)  with  previous  training  in  ESD  per-
ormed  all  the  procedures.  This  cohort  presented  a  mean
ge  of  70  ±  9  years  with  no  gender  prevalence  (17  men,
7  women).  Resection  duration  ranged  from  25  to  260  min
mean  100  ±  65  min).  Twenty-nine  resections  (85%)  were
onsidered  en  bloc  and  R0  was  also  achieved  in  26/34  (76%)
ases.  Mean  follow-up  was  14  ±  10  months  (1--36)  with  one
ocal  residual  lesion  reported  treated  with  snare  EMR.
Due  to  different  clinical  implications,  results  will  be
ivided  according  to  lesion  origin.
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Figure  1  Gastric  ESD.  (A)  Superﬁcial  lesion  in  the  gastric  antrum  with  25  mm  (T0-IIc+IIa);  (B)  mucosal  incision  with  the  Dual
Knife to  get  access  into  the  submucosal  layer;  (C)  dissection  of  the  submucosal  ﬁbers  with  the  It-Knife  2;  (D)  dissection  of  the  last
 mm,
e
fsubmucosal ﬁbers  (arrow).  (E)  piece  stretched  with  33  mm  ×  27
(T1a) with  ulcerative  component  completely  excised  (R0).
3.1.  Gastric  resections
Gastric  ESD  represented  53%  (n  =  18)  of  the  resected  lesions
(Fig.  1).  Ten  of  them  were  located  in  the  antrum,  ﬁve  were
in  the  body,  two  were  in  the  angular  incisure  and  one  was  in
the  cardia.  The  average  size  was  21  ±  5  mm,  with  a  variable
w
t
r
Table  2  Clinicopathological  characteristics.
Gastric  
(n =  18)  
Age  (mean  and  SD) 71  ±  8
[range] [57--82]
Sex (F/M) 10/8  
Lesion size  (mm,  mean  and  SD)  21  ±  5  
[range] [12--32]  
Morphology  typea (n)
T0-Is  6  
T0-IIa 4  
T0-IIa+IIc 2  
T0-IIc+IIa 6  
LST m-type  --  
Time (min,  mean  and  SD)  67  ±  34  
[range] [30--140]  
Resection, n  (%)
En bloc  17  (94)  
R0 16  (89)  
Complications  (n)
Immediate  bleeding  0  
Delayed bleeding  0  
Pathology (n)
Low-grade  dysplasia  11  
High-grade  dysplasia  2  
Intramucosal  ADC  5  
Intramucosal  SCC  --  
NETb --  
Follow-up (months,  mean  and  SD)  16  ±  11  
Residual disease  (n)  0  
Abbreviations:  SD: standard-deviation; LST: m-type laterally spreading t
cell carcinoma; NET: neuroendocrine tumor.
a Paris classiﬁcation.
b Both well differentiated (G1) with low mitotic and proliferative rat revealing  a  well  differentiated  intramucosal  adenocarcinoma
ndoscopic  morphology  (Table  2).  Resection  duration  ranged
rom  30  to  140  min  (mean  67  ±  34  min).
En  bloc  resection  was  feasible  in  17/18  (94%)  and  R0
as  achieved  in  16/18  (89%)  lesions,  without  any  complica-
ion.  In  just  one  patient,  with  an  ulcerative  lesion,  en  bloc
esection  was  not  achieved  due  to  submucosal  ﬁbrosis.  In
Rectal  Esophageal
(n  =  15)  (n  =  1)
69  ±  10 65
[57--89]
7/8  0/1
35  ±  13  12
[12--55]
6  --
--  --
--  1
--  --
9  --
142  ±  70  40
[25--260]
11  (73)  1  (100)
9  (60)  1  (100)
2  0
1  0
3  --
10  --
--  --
--  1
2  --
13  ±  9  4
1  0
umor granular mixed type; ADC: adenocarcinoma; SCC: squamous
es (<2 mitoses per high-power ﬁeld; Ki-67 <2%).
194  J.  Rodrigues  et  al.
Table  3  Non-R0  resections  characterization.
Cases  Lesion
morphology
Lesion  size
(mm)
Resection
type
(Rx/R1)
Reason  for
non-R0
Histology  Management  Follow-up
Gastric  lesions
1 T0-IIc+IIa
(gastric
body)
25  Rx  Piecemeal  (>2
fragments)
Ulcerative
intramucosal
adenocarcinoma
Surgery  --
2 T0-Is
(gastric
body)
32  R1  Focal  margin
involvement
High-grade
dysplasia
Close  endoscopic
surveillance
22  months  --  no
residual  lesion
Rectal lesions
1 LST-m  type  45  Rx  Piecemeal  (2
fragments)a
High-grade
dysplasia
Close  endoscopic
surveillance
28  months  --  no
residual  lesion
2 LST-m  typeb 32  Rx  Piecemeal  (2
fragments)a
High-grade
dysplasia
Close  endoscopic
surveillance
19  months  --  no
residual  lesion
3 LST-m  type 40  Rx  Piecemeal  (>2
fragments)c
High-grade
dysplasia
Close  endoscopic
surveillance
Residual  lesion:
effective
endoscopic
treatment
(EMR)
4 LST-m  type  42  Rx  Piecemeal  (2
fragments)a
High-grade
dysplasia
Close  endoscopic
surveillance
17  months  --  no
residual  lesion
5 LST-m  type  49  R1  Focal  margin
involvement
Low-grade
dysplasia
Close  endoscopic
surveillance
16  months  --  no
residual  lesion
6 T0-Isb 30  R1  Focal  margin
involvement
High-grade
dysplasia
Close  endoscopic
surveillance
4  months  --  no
residual  lesion
a Excision in two fragments allowing the piece reconstruction stretched in the cork (histological evaluation with apparent complete
excision).
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5Lesion with severe ﬁbrosis caused by previous endoscopic or su
c Procedure converted to snare EMR.
his  case,  histological  examination  of  the  resected  pieces
howed  an  ulcerative  intramucosal  adenocarcinoma  and
urgery  was  proposed  (Table  3).  Mean  follow-up  was  16  ±  11
onths  (1--36)  with  no  local  recurrence  reported  (Table  2).
Post-procedure  pathologic  examination  revealed  high
rade  dysplasia  in  11  lesions  (61%),  low  grade  dysplasia
n  two  lesions  and  differentiated  intramucosal  adenocarci-
oma  in  the  remaining  ﬁve..2.  Rectal  resections
ifteen  rectal  lesions  (44%)  were  removed  by  ESD  (Fig.  2).  Six
f  them  were  located  in  the  distal  rectum,  six  in  the  middle
c
c
i
igure  2  ESD  in  rectal  lesion.  (A)  Lateral  spreading  tumor,  mixe
roximal rectum;  (B)  submucosal  dissection  using  the  Dual  Knife;  (C
ith hemostatic  forceps;  (D)  advanced  stage  of  the  procedure  wi
2 mm  ×  35  mm,  whose  histology  shown  tubulovillous  adenoma  with  l treatment.
nd  three  in  the  proximal  part  of  the  rectum.  The  average
ize  was  35  ±  13  mm  and  most  of  them  were  granular  mixed-
ype  lateral  spreading  tumors.  Resection  duration  ranged
rom  25  to  260  min  (mean  142  ±  70  min).  Eleven  resections
73%)  were  considered  en  bloc  and  R0  was  achieved  in  9/15
60%).  In  three  of  the  four  piecemeal  resections  the  lesion
as  obtained  in  two  fragments  allowing  the  piece  recon-
truction  stretched  in  cork.  Histological  evaluation  showed
pparent  complete  excision,  however  by  deﬁnition  it  was
onsidered  Rx  resection.  Two  cases  of  en  bloc  resection  were
onsidered  R1  (Table  3).
There  were  three  cases  of  minor  bleeding:  two  dur-
ng  the  procedure  and  controlled  endoscopically  and  one
d  granular  type,  with  coarse  nodular  areas  (T0-IIa+Is)  in  the
)  penetrating  vessel  with  minimal  bleeding  (arrow)  controlled
th  about  3/4  submucosal  dissected;  (E)  piece  stretched  with
high-grade  dysplasia  (R0).
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Figure  3  Esophageal  ESD.  (A)  Esophageal  lesion  (T0-IIa+IIc)  marked  with  coagulation  spots  few  mm  outside  the  lesion  borders;
(B) mucosal  incision  using  the  Dual  Knife;  (C)  submucosal  dissection  using  the  Dual  Knife  (arrow  --  dissection  movement);  (D)  scar
xed  
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uwithout any  immediate  complications;  (E)  piece  stretched  and  ﬁ
an intramucosal  (m3)  squamous  cell  carcinoma,  poorly  differen
delayed  bleeding  in  an  anticoagulated  patient  (managed
conservatively  without  any  local  treatment  required).  Mean
follow-up  was  13  ±  11  months  (2--28)  with  one  local  resid-
ual  lesion  reported,  endoscopically  treated  with  snare  EMR
(Table  2).
Post-procedure  pathologic  examination  revealed  high
grade  dysplasia  in  10  lesions  (67%),  low  grade  dysplasia  in
three  and  neuroendocrine  tumor  (carcinoid)  in  two.
3.3.  Esophageal  resection
One  esophageal  lesion  was  treated  at  our  institution  (Fig.  3).
It  was  located  in  the  middle  esophagus  and  its  size  was
12  mm.  Resection  duration  was  40  min.  Resection  was  con-
sidered  en  bloc  and  R0  without  complications.  Pathologic
examination  revealed  poor  differentiated  intramucosal  (m3)
squamous  cell  carcinoma.  Therefore,  surgery  was  proposed
but  the  patient  refused  it.  After  a  follow-up  time  of  4
months,  no  local  recurrence  was  reported.
4. Discussion
The  major  advantage  of  ESD  procedures  is  its  high  rate  of
en  bloc  resection,  regardless  of  lesions  size,  which  con-
tributes  to  a  decrease  in  recurrence  rate  and  leads  to  a
better  pathological  diagnosis  and  curative  resections.2,3 The
lack  of  experience  in  western  countries  may  explain  the  dif-
ferences  in  success  rates  when  compared  to  Japanese  series
(mainly  in  the  past  series).14
The  current  study  represents  a  retrospective  evaluation
of  superﬁcial  gastrointestinal  tumors  treated  by  ESD  in  a
single  Portuguese  center.  To  the  best  of  our  knowledge  it  is
the  ﬁrst  Portuguese  report  including  rectal  and  esophageal
lesions.
Due  to  its  technical  difﬁculties,  a  period  of  training  in  ani-
mal  was  ﬁrst  performed  (more  than  30  procedures  all  under
expert  supervision).  The  next  step  involved  the  participation
in  more  than  15  human  ESD  procedures,  with  performance  of
some  phases  under  expert  supervision.  As  early  proﬁciency
was  gained,  we  started.  At  ﬁrst,  most  of  the  lesions  treated
were  located  in  the  gastric  antrum.  As  more  extensive  expe-
rience  was  carried  out,  more  challenging  resections  were
performed  (larger  size,  proximal  gastric  lesions  and  then  in
different  gastrointestinal  locations).  This  kind  of  approach
led  us,  in  gastric  lesions,  to  a  success  rate  (94%  en  bloc  and
89%  R0)  and  an  average  resection  time  (67  min)  equivalent
to  other  international  and  Portuguese  series  reported.5--7
b
i
l
rin  cork  with  20  mm  ×  13  mm;  the  histology  examination  showed
d,  completely  resected.
raditionally,  ESD  emerged  in  order  to  allow  en  bloc
esection  of  lesions  with  more  than  2  cm,  normally  not
ossible  by  conventional  EMR  techniques.  However,  further
nalysis  showed  that  even  smaller  gastric  lesions  may  bene-
t  from  ESD  excision  compared  with  EMR.  For  gastric  lesions,
atanebe  et  al.  and  Simura  et  al.  reported  signiﬁcantly
igher  complete  resection  rates  with  ESD  than  with  EMR  for
esions  larger  than  10  mm.15,16 In  other  study,  Hoteya  et  al.
howed  that  complete  resection  rates  were  overwhelmingly
etter  for  ESD  than  for  EMR  even  for  lesions  between  5
nd  10  mm  in  diameter,  regardless  of  gastric  location.17
hese  excellent  results  in  the  stomach,  namely  over  EMR,
ade  ESD  the  therapy  of  choice  for  well  differentiated  non-
lcerative  early  gastric  cancers,  irrespective  of  its  size  and
ocation,  and  for  small  ulcerative  early  cancers  (less  than
 cm),  as  recently  proposed  by  Spanish  guidelines.18
Also  in  the  esophagus,  after  proper  training,  ESD  has  been
howing  high  technical  success  rates  associated  with  a  low
ncidence  of  complications.19--21 Although  most  published
ata  is  from  eastern  countries,  a  recent  large  European
eries  conﬁrms  these  results.22 Our  experience  in  esophageal
esion  resection  is  still  scarce.  Only  one  patient  was  treated.
echnical  success  was  achieved  although  resection  was  con-
idered  not  curative  due  to  histopathological  features  (poor
ifferentiated  intramucosal  squamous  cell  carcinoma).20 In
ontrast  to  gastric  lesions,  esophageal  ESD  and  EMR  have
hown  similar  complete  resection  rates  for  lesions  with  less
han  15  mm  with  better  outcomes  for  ESD  over  EMR  just
or  larger  lesions.13 In  our  case  the  lesion  had  only  12  mm,
owever  we  chose  an  ESD  resection  to  ensure  proper  free-
umor  margins  due  to  the  suspicion  of  poorly  differentiated
eoplasm  in  diagnostic  biopsies  (dimension  of  the  resected
iece:  21  mm  ×  18  mm).
Compared  with  others  locations,  in  our  series,  rec-
al  lesion  resections  were  more  time  consuming  (ranging
rom  25  to  260  min)  with  a  lower  en  bloc  (n  =  11,  73%)
nd  R0  (n  =  9,  60%)  resections.  These  results  can  in
art  be  explained  by  features  of  resected  lesions  such
s  large  dimension  (excluding  the  two  neuroendocrine
ases  --  smaller  lesions  --  mean  lesion  dimension:  38  mm
20--55  mm])  and  heavier  submucosal  ﬁbrosis  in  some  cases
ue  to  previous  endoscopic/surgical  treatment  attempts
two  cases).  Nevertheless,  we  just  had  one  case  of  resid-
al  tissue  in  our  follow-up  period,  successfully  treated
y  snare  EMR.  Although  R0  resection  was  achieved  just
n  9/15  lesions,  there  were  three  additional  cases  where
esions  were  obtained  in  two  fragments  allowing  the  piece
econstruction.  In  these  cases  the  histological  evaluation
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howed  apparent  complete  excision,  considered  R0  in  some
eries.7,23 In  two  cases,  resection  was  considered  R1.
owever,  in  the  follow-up  period,  no  residual  lesion  was
ocumented  in  both  cases,  which  make  complete  excision
ikely.  We  hypothesize  that  cautery  artifacts  or  small  frag-
entation  of  the  tumor-free  margins  during  the  procedure
ight  be  responsible  for  a  non-R0  resection  in  both  cases.
e  had  no  cases  of  major  complications,  reporting  just  three
inor  bleeding  cases  without  clinical  impact.  Our  results
re  similar  to  other  European  series  reported.24 Despite  the
rowing  acceptance  in  Japan,  the  beneﬁt  of  ESD  over  EMR  in
he  colon  continues  to  be  contested  by  many  western  endo-
copists.  Indeed,  in  spite  of  a  higher  en  bloc  rate,  better
istological  examination  and  lower  relapse  rate,  colorectal
SD  is  usually  more  time  consuming,  technically  difﬁcult  and
as  a  higher  risk  of  complications  when  comparing  to  EMR.25
herefore,  it  is  recognized  the  need  for  structured  train-
ng  system  to  enhance  trainee  experience  and  to  reduce  the
isks  of  complications.  However,  there  are  differences  from
est  to  Japan,  such  as  the  availability  of  qualiﬁed  mentors,
he  pathology  seen  and  trainee’s  background.  An  algorithm
or  western  physicians  which  integrates  both  hands-on  train-
ng  courses,  animal  model  work  as  well  as  visits  to  expert
enters  has  been  proposed.  After  having  experience  with
astric  ESD,  endoscopists  can  gradually  expand  to  cases  of
ncreasing  difﬁculty  such  as  those  with  colon  location.  Then,
 training  continuum  with  books,  journals,  conferences,  live
emonstrations,  and  visits  to  expert  centers  is  essential  to
aintain  proﬁciency.26 Recognizing  its  technical  challenges,
t  this  time  we  believe  that  colorectal  ESD  should  be  per-
ormed  in  selected  patients,  particularly  in  rectal  lesions
lower  risk  of  free  perforation  and  surgical  option  poten-
ially  more  crippling)  when  curative  resection  is  expected
ust  after  a  careful  histological  assessment  (risk  of  minimal
ubmucosal  invasion).  Moreover,  ESD  in  rectum  has  shown  to
e  as  efﬁcient  as  surgical  transanal  resections,  with  a  lower
orbidity  and  shorter  hospital  stay.25,27,28
When  compared  to  surgery,  ESD  is  also  a  minimal  invasive
pproach  that  seems  to  be  preferred  by  patients.  Indeed,
n  our  series  one  patient  accepted  ESD  but  refused  surgi-
al  approach  when  it  was  proposed  due  to  a  non-curative
ndoscopic  resection.  This  choice  can  be  a  reﬂection  of  ESD
afety  proﬁle.  We  report  only  minor  complications  (bleed-
ng)  in  three  patients  (8%),  all  of  them  from  rectal  lesion
esections,  one  of  them  previously  treated  by  surgery.  Our
esults  are  similar  to  those  reported  by  other  Western  and
apanese  series.21,29,30
Although  not  formally  recommended,  biopsy  specimens
ere  routinely  taken  from  post-ESD  scar  during  this  ini-
ial  experience  period  in  great  part  due  to  differences  in
carring  between  patients.  However,  we  report  only  one
esidual  rectal  lesion  (after  piecemeal  resection)  which  was
ndoscopically  seen.  Routine  follow-up  biopsies  at  the  endo-
copic  resection  scar  may  not  be  necessary,  unless  it  is  an
x  or  R1  resection  or  if  there  is  an  endoscopic  suspicious  of
esidual/recurrent  disease  during  a  follow-up  endoscopy.31
There  are  some  limitations  to  our  data  analysis.  Firstly,
ur  population  is  small  compared  to  other  Eastern  series.
econdly,  our  follow-up  time  is  short.  So  we  still  cannot
orrectly  analyze  our  long-term  outcome.
In  conclusion,  ESD  represents  a  signiﬁcant  advance
n  therapeutic  endoscopy  by  increasing  the  capacity  ofJ.  Rodrigues  et  al.
ndoscopic  curative  resections.  Given  our  present  results,
e  believe  that  the  ESD  technique  is  feasible  and  safe  in
ur  environment.
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